Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion (Q77135127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

B C Dash

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

T A Harikrishnan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R Goila

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

S Shahi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

S Husain

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

A C Banerjea

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

395-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

In vivo studies with antisense oligonucleotides

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

The chemistry of self-splicing RNA and RNA enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

A small catalytic oligoribonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Simple RNA enzymes with new and highly specific endoribonuclease activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Controlled, targeted, intracellular expression of ribozymes: progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

The potential of ribozymes as antiviral agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Anti-gene therapy: the use of ribozymes to inhibit gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Ribozymes as potential anti-HIV-1 therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Development of HIV vectors for anti-HIV gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

A general purpose RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Reovirus protein sigma 1 translated in vitro, as well as truncated derivatives of it that lack up to two-thirds of its C-terminal portion, exists as two major tetrameric molecular species that differ in electrophoretic mobility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

First report of a healthy Indian heterozygous for delta 32 mutant of HIV-1 co-receptor-CCR5 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

The purification fo four strains of poxvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

21 January 2018

2 references

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

inferred from DOI database lookup

7 January 2021

based on heuristic

A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900799-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(98)00799-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714550%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference